Search
Powered By HealthLine
Special Offers
Health Tools
 Bipolar Basics
 Depression Treatment
 Depression Support Groups
 Anxiety Symptoms
 Quiz: Depression Basics
Featured Conditions
 Schizophrenia
 Anxiety
 Depression
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Doctors Warn of new Social Drug Abuse

Ivanhoe Newswire


(Ivanhoe Newswire) -- A new recreational drug is sending patients to the hospital with life-threatening symptoms!

The case of an 18-year-old girl who collapsed in a nightclub last May after taking a tablet containing 1-benzylpiperazine is highlighting the dangers of this new drug.

Text Continues Below



The teenager who was rushed to a London hospital emergency room was one of seven patients admitted with similar symptoms, including high blood pressure and a low body temperature.

Piperazines were developed to control worms in animals in the 1950s. They are chemically similar to amphetamine and are marketed in the United Kingdom in stores and online as the legal alternative to other recreational drugs such as ecstasy.

The manufacturers of the drugs claim they are safe, citing that 20 million pills containing piperazines have been consumed in New Zealand with no deaths or significant long-term injuries. But a prospective study in New Zealand shows 80 cases of patients who went to the emergency room with symptoms similar to those from taking amphetamines, such as nausea, vomiting, rapid heartbeat, anxiety and agitation. Fifteen of these patients had seizures after eight hours -- three had potentially life threatening incidents.

The authors conclude, "Clinicians should be aware of the potential presenting features of piperazine toxicity, particularly because commercially available urine toxicological screen kits for drugs of abuse may not detect piperazines."

This article was reported by Ivanhoe.com, which offers Medical Alerts by e-mail every day of the week. To subscribe, click on: http://www.ivanhoe.com/newsalert/.

SOURCE: The Lancet, published online April 26, 2007




Last updated 4/27/2007

Related Links
 border=
From Healthscout's partner site on depression, MyDepressionConnection.com
UNDERSTAND: Get a full understanding of depression
TREATMENT: Learn how therapy and lifestyle changes can help
DRUGS: Common drugs used to treat depression






About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy